eam2201 No Further a Mystery
This examine proposes that K2's higher adverse impact prevalence is because of, not less than partly, to distinctive JWH-018 metabolite action with the cannabinoid one receptor (CB1R), and suggests that metabolites of most drugs, but not the carboxy metabolite, keep in vitro and in vivo action at CB1Rs.Table 1 Affinities of the investigated indole